Atlas Trials

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Clinical trial NCT00671437 · COMPLETED

Trial details

NCT number
NCT00671437
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Squamous Cell
Start date
2008-06-01
Primary completion
2011-12-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.